Loading stock data…
Lixte Biotechnology Holdings, I (LIXT)
$8.04+0.85 (+11.82%)
After Hours$8.05+0.01 (+0.12%)· Last close Jun 29
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Lixte Biotechnology Holdings, Inc. in the Healthcare sector is trading at $8.04 with a market capitalization of $83M. The stock is currently near its 52-week high of $8.25, remaining 87.9% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.99M↓ | -$1.82M↓ | -$1.80M↓ | -$774,809↓ | -$706,940 |
| Net Income | -$1.92M↑ | -$2.54M↓ | -$1.98M↓ | -$775,673↓ | -$709,555 |
Peer Comparison
JNJUNHPFE
Fundamentals
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$83.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.05
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-90.92%
Volume
Today's trading volume
769,432
